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Abstract
Background: Echocardiography is widely used to optimize CRT programming. A novel intracardiac 
electrogram method (IEGM) was recently developed as an automated programmer-based method, 
designed to calculate optimal atrioventricular (AV) and interventricular (VV) delays and provide 
optimized delay values as an alternative to standard echocardiographic assessment.               
Objective: This study was aimed at determining the reliability of this new method. Furthermore the 
comparability   of   IEGM   to   existing   echocardiographic   parameters   for   determining   optimal 
conduction   delays   was   verified.                                                                
Methods: Eleven patients (age 62.9± 8.7; 81% male; 73% ischemic), previously implanted with a 
cardiac resynchronisation therapy defibrillator (CRT-D) underwent both echocardiographic and 
IEGM-based   delay   optimization.                                                                      
Results: Applying the IEGM method, concordance of three consecutively performed measurements 
was found in 3 (27%) patients for AV delay and in 5 (45%) patients for VV delay. Intra-individual 
variation between three measurements as assessed by the IEGM technique was up to 20 ms (AV: 
n=6; VV: n=4). E-wave, diastolic filling time and septal-to-lateral wall motion delay emerged as 
significantly different between the echo and IEGM optimization techniques (p < 0.05). The final AV 
delay setting was significantly different between both methods (echo: 126.4 ± 29.4 ms, IEGM: 183.6 
± 16.3 ms; p < 0.001; correlation: R = 0.573, p = 0.066). VV delay showed significant differences 
for optimized delays (echo: 46.4 ± 23.8 ms, IEGM: 10.9 ± 7.0 ms; p <0.01; correlation: R = -0.278, p 
=   0.407).                                                                                  
Conclusion: The automated programmer-based IEGM-based method provides a simple and safe 
method to perform CRT optimization. However, the reliability of this method appears to be limited. 
Thus, it remains difficult for the examiner to determine the optimal hemodynamic settings. 
Additionally, as there was no correlation between the optimal AV- and VV-delays calculated by the 
IEGM method and the echo optimization, the use of the IEGM method and the comparability to the 
echo has not been definitely clarified.                                                                                           
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Introduction
Cardiac resynchronisation therapy (CRT) with biventricular pacing has become an established 
electrophysiologic solution for patients with medically-refractory congestive heart failure (CHF) 
due to asynchronous cardiac contractions. Various studies have demonstrated improvement in 
symptoms, quality of life exercise tolerance and survival [1,2]. Despite clinical improvements in 
the majority of patients, up to 30% of CRT patients are non-responders [3,4]. There are several 
reasons for CRT failure, such as suboptimal device programming, incorrect positioning of the 
LV lead, or even residual intra- or interventricular dyssynchrony.                            
Intracardiac delay optimization of biventricular pacing devices has become an important tool to 
improve CRT therapy and the quality of life of non-responders. Optimization of atrioventricular 
(AV) and interventricular (VV) delays have been shown to influence hemodynamics [5-7]. 
Optimal AV timing increases the left ventricular preload by coupling atrial contraction to the 
beginning   of   ventricular   systole.   VV-delay   optimization   with   sequential   pacing   can 
incrementally improve cardiac function compared with simultaneous biventricular pacing, 
presumably by reducing both inter- and intra-ventricular dyssynchrony.The most common, 
proven, and tested method for AV and VV optimization is echocardiography.  However, 
echocardiography is time-consuming, so the time constraints and the lack of resources to 
perform the required measurements lead to a low frequency of timing optimization in the CRT 
patients. A novel intracardiac electrogram (IEGM) method was recently developed as an 
automated programmer-based method, designed to calculate optimal AV- and VV-delays and 
provide optimized delay values as an alternative to the standard echocardiographic procedure 
[8]. The purpose of this trial was to determine the reliability of this new method of AV and VV 
delay optimization since but a few such measurements have been generated. Furthermore, the 
comparability of IEGM to the best-known echocardiographic procedure for determining optimal 
conduction   delays   was   verified.                                                                    
Material   and   Methods                                                                                      
Patient   Selection                                                                                    
All patients previously implanted with a St. Jude medical cardiac resynchronization therapy 
defibrillator Atlas HF (CRT-D) were enrolled in this study. Inclusion criteria for CRT were an 
ejection fraction <35%, a left ventricular end diastolic diameter > 55 mm, NYHA class III or IV 
despite optimal medical therapy, and a QRS width >140 mm. The pacing mode was DDD with a 
maximal tracking rate of 130 beats per minute (bpm). Optimization of AV- and VV-delay was 
performed about 6 month after initiation of CRT, a period after which the main beneficial effects 
of CRT have taken place.                                                                                      
Patients were excluded from the study if they (1) had no intrinsic atrial activity (atrial rate <40 
bpm), (2) had atrial fibrillation at the time of study testing, or (3) were unable to provide 
analyzable   echocardiographic   images   (e.g.   due   to   an   inadequate   acoustic   window).
Study   Protocol                                                                                                
All measurements took place during the morning hours. First, a routine follow-up of the  CRT 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (2): 91-101 (2009)N Reinsch, C Buhr, S Huptas, T Buck, T Konorza, H Wieneke,  R Erbel, “Reliability       93 
Of A Novel Intracardiac Electrogram Method For AV And VV Delay Optimization And 
Comparability To Echocardiography Procedure For Determining Optimal Conduction Delays 
In CRT Patients”
device was conducted.  Then, the IEGM evaluation was performed  using the automated 
programmer optimization algorithm [8]. Three consecutive measurements were performed. The 
heart rate was stable at ± 5 bpm during the IEGM method of AV- and VV- delay optimization. 
In the case of variations between the serial measurements, the three consecutive cycles were 
averaged for final programming.                                                                                       
Finally, all patients were tested with the echo-guided-optimization as described below. An echo 
was performed directly after the IEGM evaluation. All echocardiographic measurements were 
obtained by a second, independent observer.                                                
Echocardiographic AV and VV delay optimization method                                     
AV-delay was optimized using the Doppler mitral inflow method. In this method, the AV delay 
that optimized the timing of mitral valve closure to occur simultaneously with the onset of left 
ventricular systole was calculated from pulsed Doppler mitral waveforms. The VV delay 
associated with the highest aortic time velocity (aortic VTI) integral was considered optimal. 
The heart rate was stable at ± 5 bpm during echo-guided-optimization of AV- and VV-delay.      
Quantitative measurements were performed according to standard criteria published by the 
American Society of Echocardiography [9]. The ultrasound system used was a VIVID 7 (GE 
Medical Systems, Milwaukee, WI, USA). The ejection fraction (LV-EF), and the left ventricular 
end diastolic and systolic volumes (LVEDV and LVESV) were calculated according to the 
biplane modified Simpson's rule [10]. The left ventricular internal diameter in diastole (LVIDd) 
and systole (LVIDs) were measured in the parasternal long axis view using the M-mode. The 
degree of mitral regurgitation (MR) was assessed according to the American Society of 
Echocardiography guidelines in orthogonal apical echocardiographic images as the average of 
the maximal areas of the colour flow Doppler regurgitant jet within the left atrium, and also as 
the ratio of the regurgitant jet area to the left atrial area [11]. Pulsed Doppler velocity signals of 
transmitral flow were recorded at 100 mm/s with the sample volume at the tips of the mitral 
valve leaflets. Peak velocities were measured during rapid LV filling (E-wave) and atrial 
contraction (A-wave), and the velocity ratio (E/A) was calculated. Tissue Doppler imaging 
(TDI) of the septal-to-lateral wall motion delay (SLWMD) was performed. The technique of 
using tissue Doppler imaging has been recently described [12]. The left ventricular pre-ejection 
period (LVPEP) was calculated using Doppler aortic flow. The right ventricular pre-ejection 
period was calculated using Doppler pulmonary flow. The systemic cardiac output was 
calculated measuring the velocity time integral (VTI) across aortic Doppler flow.             
Statistical   analysis                                                                          
Continuous variables are given as the mean ± S.E.M. The paired t-test was used to compare 
echocardiographic measurements. The parameters compared were the LV-EF, LVEDV, LVESV, 
LVIDd, LVIDs, degree of MR, E-wave and A-wave. The Mann-Whitney-U test was used to 
compare the E/A ratio and the ∆ LVPEP – RVPEP. A measurement of the linear association 
between two variables was evaluated using the Pearson correlation coefficient. A p < 0.05 was 
considered statistically significant for all tests.                                                               
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Results
Patient   Population                                                                                    
Eleven patients with severe heart failure were enrolled in this study. Table 1 presents the clinical 
characteristics obtained at the time of examination of all patients. The study population consisted 
of 81% males, with a mean age of 62.9 ± 8.7 years. Nine (81%) patients had complete left 
bundle brunch block and 2 patients (19%) had complete right bundle brunch block. The mean 
QRS duration was 160.4 ± 29.6 milliseconds (ms). Eight (73%) patients had known coronary 
heart disease (CHD) and 3 patients (27%) had dilated cardiomyopathy (DCM). No adverse 
events were reported during the study.The left ventricular ejection fraction, as assessed by the 
Simpson biplane method, was 30.3 ± 9.0%. The left ventricular enddiastolic diameter was 73.5 ± 
12.7 millimeters (mm) and the left ventricular endsystolic diameter was 59.4 ± 14.2 mm. The 
LVEDV was 239.1 ± 76.4 milliliters (ml) and the LVESV was 170.4 ± 64.1 ml. The stroke 
volume was assessed as 69.5 ± 20.6 ml.
Table 1: Clinical Characteristics for all patients
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (2): 91-101 (2009)N Reinsch, C Buhr, S Huptas, T Buck, T Konorza, H Wieneke,  R Erbel, “Reliability       95 
Of A Novel Intracardiac Electrogram Method For AV And VV Delay Optimization And 
Comparability To Echocardiography Procedure For Determining Optimal Conduction Delays 
In CRT Patients”
IEGM   method                                                                        
Table 2 shows the proposed AV- and VV-delays with the goal of maximizing hemodynamic 
performance. The differences of each measurement for AV- and VV-delay and the final setting 
are presented for each patient. Concordance for AV-delay in all consecutive measurements was 
found in 3 (27%) patients. The maximum difference of the proposed optimized AV-delay was 20 
ms between the three measurements (n = 6 patients) and 10 ms in the remaining 2 patients.       
The VV-delay was equal in 5 (45%) patients. The maximum difference of the proposed 
optimized VV-delay was 20 ms between the three measurements (n = 4 patients) and 10 ms in 
the   remaining   2   patients.                                                                      
Table 2: Different measurements of AV- and VV-delay using the IEGM method
RV = right ventricle; LV = left ventricle; ms = milliseconds
Echocardiographic values of IEGM optimization and echocardiographic delay optimization    
Table 3 summarizes the echocardiographic parameters as the mean ± SD of optimized AV- and 
VV-delay values for the IEGM method and echocardiographic measurements.The velocity of the 
E-wave as a marker of LV filling was significantly different between the echocardiographic- and 
IEGM-methods  (0.85 ± 0.27 vs. 0.75 ± 0.25   cm/sec;   p < 0.05).  There   was  no  significant 
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difference in the A-wave, and no significant difference was observed in the E/A ratio (1.58 ± 
0.93 vs. 1.78± 1.69; p = ns). Significant mitral regurgitation was present in all patients and was 
graded as mild in 6 patients, moderate in 2 patients, and severe in 3 patients. There was no 
significant difference between the optimization methods. Aortic VTI did not differ significantly 
between the methods, albeit a slight advance was shown for echocardiographic optimization 
(28.5 ± 9.6 vs. 27.0 ± 8.1 cm; p = ns).The diastolic filling time as assessed by mitral inflow was 
significantly different between echocardiographic- and IEGM-derived optimization (492.5 ± 
129.9 vs. 431.2 vs. 107.8 ms; p < 0.0001). Furthermore, the TDI of SLWMD differed 
significantly between both methods (37.9 ± 26 vs. 57.9 ± 34.7 ms; p < 0.05). The LV-PEP, RV-
PEP and ∆ LVPEP– RVPEP did not reveal any significant differences with respect to the 
optimization   method.                                                                    
Table 3: Comparison of echocardigraphic measurements in CRT patients afterAV and VV delay optimization for 
the IEGM- and echocardiographic methods.
VTI = velocity time integral; SLWMD = septal to lateral wall motion delay;PEP = pre-ejection period
Comparison of optimized delay values of echocardiography vs. IEGM                        
The optimal echo AV delay was 126.4 ± 29.4 ms and the optimal IEGM AV delay was 183.6 ± 
16.3 ms (p < 0.001). There was no correlation between optimal echo and IEGM delays (R = 
0.573; p = 0.066). The optimal VV delays showed significant differences as well for optimized 
echo delays (46.4 ± 23.8 ms) vs. IEGM delays (10.9 ± 7.0 ms; p <0.01). There was no correlation 
between optimal echo and IEGM delays (R = -0.278; p = 0.407). In 7 of the 11 patients (64%), 
RV pacing preceding LV pacing was optimal using the IEGM (Table 2) and echo methods, 
respectively.
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Discussion
The aim of this study was to determine the reliability of the IEGM method of AV- and VV-delay 
optimization, as well as the comparability to the echocardiographic procedure for determining 
optimal conduction delays. Our results have demonstrated that though simple and safe to perform, 
(1)  the   IEGM  method   displays   a  significant   variability  between   consecutively  performed 
measurements and (2) there was no correlation between the optimal AV- and VV-delays 
calculated by the IEGM method and the echo-derived optimization, (3) resulting in different 
hemodynamic   parameters,   mainly   of   the   diastolic   function.                                        
IEGM-based   delay   optimization                                                                    
The automated programmer-based IEGM method is a quick, safe, and easy tool for the 
optimization of AV- and VV-delays in patients with CRT devices [8]. However, these criteria do 
not reflect the reliability of this method for the optimization of the cardiac activation pattern. Our 
results demonstrate a variability of the IEGM method of up to 20 ms in 3 consecutively performed 
serial optimization procedures both for AV- as well as the VV-delays. The reliability of all 
consecutively performed measurements was observed in less then one-half of the patients 
concerning both AV- and VV-delay optimization. This is of major interest as simultaneous 
biventricular pacing improves cardiac performance compared with the native rhythm, and 
hemodynamics can be further improved by individually programming both AV- and VV-delay 
[13-15]. As previoulsy published, pre-excitation by 20ms of 1 chamber has been shown to 
influence hemodynamics significantly [16]. This clearly demonstrates that the differences in 
delays occurring in our patients may significantly limit the benefit of CRT by means of 
suboptimal   delay   settings.                                                                
Due to a lack of chronic data on the difficulties of the IEGM-based delay optimization method, 
there is currently no further information regarding the expected variability or measurement-
influencing factors of optimized delays in our patients that might explain these differences in 
measurements. Previously published, temporal variations of echocardiography-based Doppler- or 
two-dimensional parameters and echo-guided optimized atrioventricular and interventricular 
delays during follow-up have been described, too [17,18]. Nevertheless, the intra-examination 
variability of consecutive established IEGM delays in this study appear to be superior, thoroughly 
influencing the optimal clinical benefit significantly.  Certainly, randomized  double-blinded 
controlled and multicenter studies are needed to determine this method and to identify limitations 
that   might   result   using   the   IEGM   method.                                                      
Comparison of the IEGM method with echocardiography                                   
The results of our study showed that there was no correlation between the optimal AV and VV 
interval settings of these methods. These data correspond significantly with the findings of van 
Gelder et al. [19], who also showed no correlation between the optimal settings of the VV interval 
from the IEGM method and the invasive LVdp/dt measurements. However, our study contrasts the 
results of Becker et al. [8], who reported an optimal VV interval of 15±44 ms for the 
echocardiographic optimization and 13±20 ms for the IEGM method, as well as an optimal AV 
delay of 165±28 ms for the echocardiographic optimization and 178±16 ms for the IEGM method. 
Van Gelder et al. [19] assumed that the remarkably short VV delay determined by the IEGM 
method might be explained because of a different lead position of the left and right ventricular 
leads.
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Additionally, we have reported that in the echo optimization there was a significant progressive 
lengthening of the LV diastolic filling time (DFT) and transmitral velocity during early diastolic 
filling (E-wave). This is of interest as these parameters may reflect improvements of diastolic 
function.   The   fact   that   CRT   improves   diastolic   dysfunction   itself   has   been   previously 
demonstrated [20-22]. Thus, in the study of Waggoner et al. [23], pulsed-wave Doppler (PWD) 
mitral   E-wave   velocity   decreased   and   E-wave   duration   and   DFT   increased   significantly 
immediately after CRT. Moreover, CRT was shown to enhance diastolic filling patterns in both 
responder and nonresponder patients related to an improvement in symptoms [24]. However, as 
suboptimal pacemaker programming post-CRT may be a determinant for lack of optimal benefit, 
optimization of AV-delay in addition to CRT may lead to a further increase of myocardial 
function [13,25].  In a recent analysis by Waggoner et al. [23,26], it was shown that in heart 
failure patients receiving CRT, improvement in LV diastolic function is coupled to improvement 
in LV systolic function.                                                                                             
We also showed the SLWMD was significantly different between the echo- and IEGM-based 
optimization. This is of interest, because the different SWLMD might result in divergent VV-
delays of the echo and the IEGM methods. Consequently, as a marker of intraventricular 
dyssynchrony, decreased SLWMD indicates a reduction of dyssynchrony and enhanced response 
to CRT [27]. Thus, in a previous study, SLWMD decreased significantly in responders compared 
to non-responders. This led to improvement in the 6-min walk test, ejection fraction and a further 
decrease of left ventricular end-diastolic and end-systolic diameters in the responder group [28]. 
Recently, acute hemodynamic studies have demonstrated an enhanced response to CRT with 
additional improvements in left ventricular synchrony and left ventricular function due to 
optimization of the VV interval [27,29]. Sequential biventricular pacing with the VV-delay 
optimized enhances the response to CRT compared to simultaneous CRT as it improves systolic 
function and reduces mitral regurgitation and LV volumes in patients with heart failure and 
electromechanical delay [30]. VV optimization has been shown to improve NYHA class and 
LVEF at follow-up [31].                                                                                                           
Study   limitations
The number of patients was small. This study might delineate issues which should be verified in 
additional studies. Certainly, randomized double-blinded controlled and multicenter studies should 
follow this report. Furthermore, it has been shown that exercise can have a significant influence on 
ventricular dyssynchrony in heart failure patients [32]. For this study, all data were collected in a 
resting state. However, this may not reflect the hemodynamic effects when the patients are active 
and differences in the IEGM and echocardiographic methods may vary.The best method for 
adjusting the AV and VV delay to maximise longterm clinical responses is not known yet. While 
the echocardiogram optimization techniques are well established and supported by several clinical 
trials, the clinical utility of the IEGM method needs further clarification. The lack of clinical 
response measures over time was also a limitation of this study.                              
Conclusion
The automated programmer-based IEGM-based method provides a simple and safe method to 
perform CRT optimization. However, the reliability of this method appears to be limited. Thus, it 
remains difficult for the examiner to determine the optimal hemodynamic settings. Additionally, 
as there was no correlation between the optimal AV- and VV-delays calculated by the IEGM 
method and the echo optimization, the use of the IEGM method and the comparability to the echo 
has     not  been  definitely  clarified.  Further  studies  are  needed  to  elucidate  the  varieties  of 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (2): 91-101 (2009)N Reinsch, C Buhr, S Huptas, T Buck, T Konorza, H Wieneke,  R Erbel, “Reliability       99 
Of A Novel Intracardiac Electrogram Method For AV And VV Delay Optimization And 
Comparability To Echocardiography Procedure For Determining Optimal Conduction Delays 
In CRT Patients”
measurements of the IEGM method and the discrepancies between both methods found in the 
current   study.                                                                                            
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